Developing guideline recommendations about tests: educational examples of test-management pathways

IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Mariska Tuut, Jochen Cals, Jesse Jansen, Jako S Burgers
{"title":"Developing guideline recommendations about tests: educational examples of test-management pathways","authors":"Mariska Tuut, Jochen Cals, Jesse Jansen, Jako S Burgers","doi":"10.1136/bmjebm-2024-112984","DOIUrl":null,"url":null,"abstract":"Recommendations about healthcare related testing in guidelines are common. Tests can be used for several purposes: screening, surveillance, risk classification, diagnosis, staging, treatment triage, determination of prognosis and monitoring/follow-up.1 The development of testing recommendations in guidelines is challenging, especially because the benefit of a test not only depends on test characteristics, such as sensitivity and specificity, but also on population characteristics and test consequences, such as management.2–4 Furthermore, the role of a new test in comparison to the existing testing scenario should be defined, since this influences the interpretation of the new test’s value. The following roles of new tests have been identified in the literature: triage, replacement, add-on, and parallel/combined.5 As with treatment, testing can have negative consequences, including physical impairment, psychological distress, disease labelling, and costs.6 There is limited evidence on harms of testing, and healthcare professionals often overestimate its benefits while underestimating its harms.7 This is also true for patients' expectations of testing.8 Additionally, testing occasionally yields unexpected and coincidental findings, which may result in additional testing and treatment. There is a lack of transparency in processing the evidence and considerations that support testing recommendations in guidelines.9 To facilitate the development of test recommendations, we determined the minimum required knowledge for guideline panel members involved, supplementing the competency-based framework available for guideline development.10 11 The concept of the test-management pathway (figure 1) appeared key to understand. Figure 1 Test-management pathway concept. During our developmental study, the need for practical examples of test-management pathways became apparent.10 In our subsequent teach-the-teacher workshop at the 2023 Guideline International Network conference,12 participants requested additional elaboration of pathways for different test outcomes (such as false positives and false negatives) being helpful for explaining the test-management pathway concept to guideline …","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":"201 1","pages":""},"PeriodicalIF":9.0000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Evidence-Based Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjebm-2024-112984","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Recommendations about healthcare related testing in guidelines are common. Tests can be used for several purposes: screening, surveillance, risk classification, diagnosis, staging, treatment triage, determination of prognosis and monitoring/follow-up.1 The development of testing recommendations in guidelines is challenging, especially because the benefit of a test not only depends on test characteristics, such as sensitivity and specificity, but also on population characteristics and test consequences, such as management.2–4 Furthermore, the role of a new test in comparison to the existing testing scenario should be defined, since this influences the interpretation of the new test’s value. The following roles of new tests have been identified in the literature: triage, replacement, add-on, and parallel/combined.5 As with treatment, testing can have negative consequences, including physical impairment, psychological distress, disease labelling, and costs.6 There is limited evidence on harms of testing, and healthcare professionals often overestimate its benefits while underestimating its harms.7 This is also true for patients' expectations of testing.8 Additionally, testing occasionally yields unexpected and coincidental findings, which may result in additional testing and treatment. There is a lack of transparency in processing the evidence and considerations that support testing recommendations in guidelines.9 To facilitate the development of test recommendations, we determined the minimum required knowledge for guideline panel members involved, supplementing the competency-based framework available for guideline development.10 11 The concept of the test-management pathway (figure 1) appeared key to understand. Figure 1 Test-management pathway concept. During our developmental study, the need for practical examples of test-management pathways became apparent.10 In our subsequent teach-the-teacher workshop at the 2023 Guideline International Network conference,12 participants requested additional elaboration of pathways for different test outcomes (such as false positives and false negatives) being helpful for explaining the test-management pathway concept to guideline …
制定有关测试的指导建议:测试管理途径的教育实例
在指南中提出与医疗保健相关的检验建议很常见。检验可用于多种目的:筛查、监测、风险分类、诊断、分期、治疗分流、确定预后和监测/随访。1 在指南中制定检验建议具有挑战性,特别是因为检验的益处不仅取决于检验的特点,如灵敏度和特异性,还取决于人群特点和检验的后果,如管理。5 与治疗一样,检验也会产生负面影响,包括身体损伤、心理困扰、疾病标签和费用。6 有关检验危害的证据有限,医护人员往往高估了检验的益处而低估了其危害。9 为促进检验建议的制定,我们确定了相关指南小组成员所需的最低知识要求,以补充指南制定中基于能力的框架。10 11 检验管理路径的概念(图 1)似乎是理解的关键。图 1 检验管理路径概念。在 2023 年指南国际网络会议12 上举办的 "教师授课 "研讨会上,与会者要求进一步阐述不同试验结果(如假阳性和假阴性)的路径,这有助于向指南专家解释试验管理路径概念。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Evidence-Based Medicine
BMJ Evidence-Based Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
8.90
自引率
3.40%
发文量
48
期刊介绍: BMJ Evidence-Based Medicine (BMJ EBM) publishes original evidence-based research, insights and opinions on what matters for health care. We focus on the tools, methods, and concepts that are basic and central to practising evidence-based medicine and deliver relevant, trustworthy and impactful evidence. BMJ EBM is a Plan S compliant Transformative Journal and adheres to the highest possible industry standards for editorial policies and publication ethics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信